This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Astec Co., Ltd., Astec, Inc.. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Michelle Perugini: Innovator in AI-Driven Genetic Testing
Introduction
Michelle Perugini is a prominent inventor based in Adelaide, Australia. She has made significant contributions to the field of artificial intelligence, particularly in the realm of genetic testing and embryo selection. With a total of 2 patents, her work is at the forefront of integrating AI technology into medical applications.
Latest Patents
Michelle's latest patents include a "Method and system for performing non-invasive genetic testing using an artificial intelligence (AI) model." This innovative system utilizes AI to non-invasively estimate the presence of various aneuploidies and mosaicism in embryo images prior to implantation. The AI model is designed to group aneuploidies and mosaicism with similar risks and employs multiple training models to enhance accuracy. Another notable patent is the "Method and system for selecting embryos," which describes an AI computational system that generates an embryo viability score from a single image. This system aids in selecting embryos for implantation during In-Vitro Fertilisation (IVF) procedures.
Career Highlights
Throughout her career, Michelle has worked with notable companies such as Astec Co., Ltd. and Astec, Inc. Her expertise in AI and genetic testing has positioned her as a leader in her field, contributing to advancements that have the potential to improve outcomes in reproductive health.
Collaborations
Michelle has collaborated with several professionals in her field, including Jonathan Michael MacGillivray Hall and Donato Perugini. These collaborations have further enriched her research and development efforts, leading to innovative solutions in embryo selection and genetic testing.
Conclusion
Michelle Perugini's work exemplifies the intersection of artificial intelligence and medical technology. Her patents reflect a commitment to enhancing reproductive health through innovative solutions. Her contributions are paving the way for future advancements in genetic testing and embryo selection.